{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T16:51:25Z","timestamp":1760979085502},"reference-count":47,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2003,9,19]],"date-time":"2003-09-19T00:00:00Z","timestamp":1063929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Investigation"],"published-print":{"date-parts":[[2003,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Erythrocyte membrane modifications in patients with cholestasis are supposed to reflect those of hepatocytes.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> Erythrocyte membrane composition (cholesterol, phospholipids, fatty acids, protein sulphydrils and carbonyls) was assessed and related to the stage of liver disease in patients with primary biliary cirrhosis before and after 1\u00a0year of ursodeoxycholate treatment.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Compared with controls, patients showed lower levels of protein sulphydrils (28\u00b79\u00a0\u00b1 7\u00b71 vs. 65\u00b76\u00a0\u00b1\u00a01\u00b78\u00a0nmol\u00a0mg<jats:sup>\u22121<\/jats:sup> prot) and accumulation of carbonyls (4\u00b77\u00a0\u00b1\u00a01\u00b77 vs. 1\u00b74\u00a0\u00b1\u00a00\u00b71\u00a0nmol mg<jats:sup>\u22121<\/jats:sup> prot). Phosphatidylethanolamine level was lower in stage III\u2013IV cirrhosis while phosphatidylcholine and cholesterol levels were higher; as a consequence the phosphatidylcholine\/sphingomyelin ratio was higher than in controls (4\u00b725\u00a0\u00b1\u00a00\u00b755 in the I\u2013II stage and 2\u00b789\u00a0\u00b1\u00a00\u00b744 in the stage III\u2013IV vs. 1\u00b761\u00a0\u00b1\u00a00\u00b730). These changes were particularly evident in patients with more advanced stages of liver disease. Protein sulphydrils and carbonyls, phosphatidylethanolamine and cholesterol levels correlated (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00\u00b705) with the histological stage of the liver disease, serum and membrane cholesterol levels were significantly related (<jats:italic>r<\/jats:italic>\u00a0=\u00a00\u00b766, <jats:italic>P<\/jats:italic> &lt;\u00a00\u00b705). One\u00a0year of ursodeoxycholate administration was accompanied by major changes of the membrane lipid composition, partial reversal of protein oxidation, and improvement of serum parameters.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> This study indicates that major alterations in protein status and lipid composition occur in erythrocyte membrane of patients with primary biliary cirrhosis. These changes were more pronounced in patients with advanced liver disease. Ursodeoxycholate was able to revert in part serum and erythrocyte alterations, especially in patients with early stages of liver disease.<\/jats:p>","DOI":"10.1046\/j.1365-2362.2003.01238.x","type":"journal-article","created":{"date-parts":[[2003,9,19]],"date-time":"2003-09-19T08:30:17Z","timestamp":1063960217000},"page":"868-874","source":"Crossref","is-referenced-by-count":5,"title":["Structural and oxidative modifications of erythrocyte ghosts in patients with primary biliary cirrhosis: relation with the disease stage and effect of bile acid treatment"],"prefix":"10.1111","volume":"33","author":[{"given":"I.","family":"Grattagliano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M.","family":"Giudetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Grattagliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. O.","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. V.","family":"Gnoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Lapadula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Palasciano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Vendemiale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,9,19]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(79)80564-5"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1982.tb08680.x"},{"key":"e_1_2_7_4_2","first-page":"319","article-title":"Lipids, lipoproteins, and cell membranes","volume":"7","author":"Harry DS","year":"1982","journal-title":"Prog Liver Dis"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840040124"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs0830353"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)38181-5"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9120(01)00208-9"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02537003"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2736(93)90216-M"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840190228"},{"key":"e_1_2_7_12_2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0022-2275(20)31668-0","article-title":"Cholesterol metabolism in primary biliary cirrhosis during simvastatin and UDCA administration","volume":"42","author":"Del Puppo M","year":"2001","journal-title":"J Lipid Res"},{"key":"e_1_2_7_13_2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0016-5085(81)90206-7","article-title":"Ethynylestradiol\u2010induced impairment of bile secretion in the rat. protective effects of S\u2010adenosyl\u2010L\u2010methionine and its implication in estrogen metabolism","volume":"80","author":"Stramentinoli G","year":"1981","journal-title":"Gastroenterology"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)34955-5"},{"key":"e_1_2_7_15_2","first-page":"98","article-title":"Erythrocyte lipid alterations in pediatric cholestatic liver disease: relationship to serum bile acids","volume":"33","author":"Cynamon HA","year":"1986","journal-title":"Hepatogastroenterology"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(93)90456-D"},{"key":"e_1_2_7_17_2","first-page":"445","article-title":"Erythrocyte membrane abnormalities in experimental biliary obstruction: comparative studies on erythrocyte membranes from rats with intra\u2010 and extrahepatic cholestasis","volume":"50","author":"Okano Y","year":"1980","journal-title":"Jpn J Exp Med"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.05339.x"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840220234"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(02)00234-9"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1996.0430"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2000.20240"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1177\/003591576706001205"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9861(63)90042-0"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(96)80324-2"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0076-6879(90)86141-H"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1139\/y59-099"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0014-2956.2001.02508.x"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2736(93)90216-M"},{"key":"e_1_2_7_30_2","first-page":"330","article-title":"Change in cholesterol levels and in lipid fatty acid composition in safflower oil fed lambs. Internat","volume":"62","author":"Muci MR","year":"1992","journal-title":"J Vit Nutr Res"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(95)90233-3"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.76.12.6361"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(79)80186-6"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2760(83)90093-0"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-8981(97)00216-7"},{"key":"e_1_2_7_36_2","first-page":"65","article-title":"Altered insulin receptor processing and membrane lipid composition in erythrocytes of cirrhotic patients","volume":"24","author":"Peterson SW","year":"1992","journal-title":"Ital J Gastroenterol"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1015563704551"},{"key":"e_1_2_7_38_2","first-page":"200","article-title":"Effects of simvastatin, a cholesterol synthesis inhibitor, on phosphatidylcholine synthesis in HepG2 cells","volume":"16","author":"Yanagita T","year":"1994","journal-title":"Clin Ther"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(97)80116-X"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)69166-5"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.79.22.6890"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840080113"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840080610"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.2310\/6650.2001.33897"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02536997"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(00)00396-8"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510290220"},{"key":"e_1_2_7_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9270(03)00022-4"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2362.2003.01238.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2362.2003.01238.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2362.2003.01238.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T18:51:03Z","timestamp":1697223063000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2362.2003.01238.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9,19]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2003,10]]}},"alternative-id":["10.1046\/j.1365-2362.2003.01238.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2362.2003.01238.x","archive":["Portico"],"relation":{},"ISSN":["0014-2972","1365-2362"],"issn-type":[{"value":"0014-2972","type":"print"},{"value":"1365-2362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,9,19]]}}}